Sharenet Sites 
Sharenet Sites
Dealing in Securities by Directors, Prescribed Officers and Company Secretary
ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively "Aspen" or "the Group")
DEALING IN SECURITIES BY DIRECTORS, PRESCRIBED OFFICERS AND COMPANY SECRETARY
In compliance with paragraph 3.63 of the Listings Requirements of the JSE Limited, shareholders are
advised of the dealings in securities as set out below:
Deferred bonus shares, awarded in 2022 in respect of the Aspen South African Management Deferred
Incentive Bonus Scheme and the Long-term Retention Share Scheme, a component of the Aspen
South African Deferred Incentive Bonus Scheme, have vested and have been delivered to the
undermentioned directors, prescribed officers and company secretary.
DIRECTORS
Director : Stephen Bradley Saad
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 32 493
Price on vesting : R 102.1107
Value of vesting : R 3 317 882.98
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Director : Sean Matthew Capazorio :
Company : Aspen Pharmacare Holdings Limited :
Date of transaction : 16 October 2025 :
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale of shares to settle the tax liability
Number of securities vested : 17 404
Price on vesting : R 102.1107
Value of vesting : R 1 777 134.62
Number of shares sold : 8 092
Volume weighted average price : R 101.6423
Highest sale price : R 102.15
Lowest sale price : R 101.36
Value of sale : R 822 489.49
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
Director : Reginald Thomas Haman
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 13 327
Price on vesting : R 102.1107
Value of vesting : R 1 360 829.30
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
Director : Reginald Thomas Haman
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of Long-Term Retention Share Scheme
Number of securities vested : 22 240
Price on vesting : R 102.1107
Value of vesting : R 2 270 941.97
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by director involved
PRESCRIBED OFFICERS
Name : Michael Guy Attridge
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 26 862
Price on vesting : R 102.1107
Value of vesting : R 2 742 897.62
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by prescribed officer involved
Name : Lorraine Angela Hill
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of deferred incentive bonus shares and
subsequent on-market sale of shares to settle the tax liability
Number of securities vested : 19 327
Price on vesting : R 102.1107
Value of vesting : R 1 973 493.50
Number of shares sold : 8 987
Volume weighted average price : R 101.6423
Highest sale price : R 102.15
Lowest sale price : R 101.36
Value of sale : R 913,459.35
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Yes
COMPANY SECRETARY
Name : Raeesa Khan
Company : Aspen Pharmacare Holdings Limited
Date of transaction : 16 October 2025
Nature of transaction : Off-market delivery of deferred incentive bonus shares
Number of securities vested : 1 769
Price on vesting : R 102.1107
Value of vesting : R 180 633.83
Class of securities : Ordinary shares
Nature of interest : Direct beneficial
Clearance obtained : Not applicable – no dealing by company secretary involved
Durban
17 October 2025
Sponsor
Investec Bank Limited
Date: 17-10-2025 04:57:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE').
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct,
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
information disseminated through SENS.
